Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy
对于局部晚期或不可切除的头颈癌,低剂量纳武利尤单抗联合诱导化疗可获得较高的缓解率和转化为根治性治疗的几率。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-19197-y
Georgy, Josh Thomas; Regi, Soumya Susan; Georgy, Rosh Varghese; Sasidharan, Balu Krishna; Joel, Anjana; Philip, Deepa Susan Joy; John, Ajoy Oommen; Thumaty, Divya Bala; Marimuthu, Praveen Kumar; Jambunathan, Prashant; Harikrishna, Kovilapu; Thomas, Zachariah; Rani, N Jansi; Tirkey, Amit Jiwan; Thomas, Meera; Isiah, Rajesh; Singh, Ashish